Company
Headquarters: Berlin, Germany
Employees: 3
CEO: Mr. Wade Menpes-Smith
€120,311
EUR as of Nov. 1, 2022
US$118,160
Company | Market Cap (USD) |
---|---|
GE HealthCare | $34.86 B |
Veeva Systems Inc. | $29.97 B |
M3, Inc. | $11.24 B |
Change Healthcare Inc. | $9.03 B |
Signify Health, Inc. | $8.38 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Aladdin Healthcare Technologies SE, through its subsidiary, Aladdin Healthcare Technologies Ltd, develops software solutions for the storage and management of health information using blockchain technology. It specializes in technologies, such as blockchain, machine learning, and artificial intelligence. The company engages in the research and development of Artificial Intelligence Early Diagnosis, an artificial intelligence powered data analysis platform for brain imaging; Health Risk Assessment platform that assesses the risk of cardiovascular, as well as diabetes and kidney related diseases in patients; and Artificial Intelligence assisted Drug Discovery platform to identify various small molecule drug compounds with multiple age-related diseases, including Alzheimer's, Parkinson's, and SARS-CoV-2. It uses blockchain, machine learning, artificial intelligence, and advanced predictive data analytics for the early diagnosis of chronic diseases. The company was founded in 2014 and is based in Berlin, Germany.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Aladdin Healthcare Technologies Holding SE has the following listings and related stock indices.
Stock: FSX: NMI wb_incandescent
Stock: XETR: NMI wb_incandescent